Herbert C. Wenger

837 total citations
18 papers, 659 citations indexed

About

Herbert C. Wenger is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Herbert C. Wenger has authored 18 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Herbert C. Wenger's work include Receptor Mechanisms and Signaling (7 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Herbert C. Wenger is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Herbert C. Wenger collaborates with scholars based in United States. Herbert C. Wenger's co-authors include John M. Stavorski, Carl T. Ludden, Clement A. Stone, Charles A. Ross, Charles S. Sweet, Dennis M. Gross, Backlund Eo, Alexander Scriabine, E H Ulm and David A. Weitz and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Herbert C. Wenger

18 papers receiving 576 citations

Peers

Herbert C. Wenger
Carl T. Ludden United States
R Hahn United States
John M. Stavorski United States
Walter Osswald Portugal
Ho Sam Ahn United States
F Lefèvre-Borg France
Irwin H. Slater United States
Jai D. Kohli United States
T. L. B. Spriggs United Kingdom
T J Verbeuren Belgium
Carl T. Ludden United States
Herbert C. Wenger
Citations per year, relative to Herbert C. Wenger Herbert C. Wenger (= 1×) peers Carl T. Ludden

Countries citing papers authored by Herbert C. Wenger

Since Specialization
Citations

This map shows the geographic impact of Herbert C. Wenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert C. Wenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert C. Wenger more than expected).

Fields of papers citing papers by Herbert C. Wenger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert C. Wenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert C. Wenger. The network helps show where Herbert C. Wenger may publish in the future.

Co-authorship network of co-authors of Herbert C. Wenger

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert C. Wenger. A scholar is included among the top collaborators of Herbert C. Wenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert C. Wenger. Herbert C. Wenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wenger, Herbert C. & Peter K. S. Siegl. (1987). Influence of AQ-A39, a Bradycardic Agent, on Cardiovascular Responses to Isoproterenol in the Anesthetized Dog. Journal of Cardiovascular Pharmacology. 9(2). 246–253. 2 indexed citations
2.
Siegl, Peter K. S. & Herbert C. Wenger. (1985). Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. European Journal of Pharmacology. 113(3). 305–311. 3 indexed citations
3.
Siegl, Peter K. S., Herbert C. Wenger, & Charles S. Sweet. (1984). Comparison of Cardiovascular Responses to the Bradycardic Drugs, Alinidine, AQ-A 39, and Mixidine, in the Anesthetized Dog. Journal of Cardiovascular Pharmacology. 6(4). 565–574. 11 indexed citations
4.
Gross, Dennis M., Charles S. Sweet, E H Ulm, et al.. (1981). Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 552–557. 136 indexed citations
5.
Sweet, Charles S., Herbert C. Wenger, D. A. H. Taylor, & Dennis M. Gross. (1980). Central antihypertensive properties of muscimol and related structures. Brain Research Bulletin. 5. 491–496. 3 indexed citations
6.
Sweet, Charles S., Randy A. Hall, Herbert C. Wenger, et al.. (1979). Beta adrenoceptor blocking properties of MK-761.. Journal of Pharmacology and Experimental Therapeutics. 211(1). 195–199. 4 indexed citations
7.
Sweet, Charles S., Herbert C. Wenger, & Dennis M. Gross. (1979). Central antihypertensive properties of muscimol and related γ-aminobutyric acid agonists and the interaction of muscimol with baroreceptor reflexes. Canadian Journal of Physiology and Pharmacology. 57(6). 600–605. 40 indexed citations
8.
Scriabine, Alexander, Charles S. Sweet, Carl T. Ludden, et al.. (1977). Some cardiovascular effects of ST-91 and clonidine. European Journal of Pharmacology. 43(4). 333–341. 35 indexed citations
9.
Torchiana, Mary Lou, et al.. (1975). The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).. Journal of Pharmacology and Experimental Therapeutics. 194(2). 415–426. 1 indexed citations
10.
Sweet, Charles S., Herbert C. Wenger, & Theresa O’Malley. (1974). Antagonism of Hydrochlorothiazide-Induced Elevations in Plasma-Renin Activity by Methyldopa in Conscious Renal-Hypertensive Dogs. Canadian Journal of Physiology and Pharmacology. 52(5). 1036–1040. 2 indexed citations
11.
Torchiana, Mary Lou, et al.. (1972). Pharmacological antagonism of the toxic manifestations of amitriptyline and protriptyline in dogs. Toxicology and Applied Pharmacology. 21(3). 383–389. 7 indexed citations
12.
Scriabine, Alexander, John M. Stavorski, Herbert C. Wenger, Mary Lou Torchiana, & C. Addison Stone. (1970). CARDIAC SLOWING EFFECTS OF CLONIDINE (ST-155) IN DOGS. Journal of Pharmacology and Experimental Therapeutics. 171(2). 256–264. 36 indexed citations
13.
Torchiana, Mary Lou, Herbert C. Wenger, John M. Stavorski, Carl T. Ludden, & Clement A. Stone. (1966). EFFECT OF METHYLDOPA AND RELATED AGENTS ON PRESSOR RESPONSES TO TYRAMINE IN RESERPINE-PRETREATED RATS AND DOGS. Journal of Pharmacology and Experimental Therapeutics. 151(2). 242–252. 8 indexed citations
14.
Engelhardt, Edward L., Walfred S. Saari, Marcia E. Christy, et al.. (1965). Structure-Activity Relationships in the Cyproheptadine Series. Journal of Medicinal Chemistry. 8(6). 829–835. 28 indexed citations
15.
Stone, Clement A., John M. Stavorski, Carl T. Ludden, et al.. (1963). COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL. Journal of Pharmacology and Experimental Therapeutics. 142(2). 147–156. 34 indexed citations
16.
Stone, Clement A., Charles A. Ross, Herbert C. Wenger, et al.. (1962). Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.. PubMed. 136. 80–8. 33 indexed citations
17.
Stone, Clement A., Charles A. Ross, Herbert C. Wenger, et al.. (1962). EFFECT OF α-METHYL-3,4-DIHYDROXYPHENYLALANINE (METHYLDOPA), RESERPINE AND RELATED AGENTS ON SOME VASCULAR RESPONSES IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 136(1). 80–88. 9 indexed citations
18.
Stone, Clement A., Herbert C. Wenger, Carl T. Ludden, John M. Stavorski, & Charles A. Ross. (1961). ANTISEROTONIN-ANTIHISTAMINIC PROPERTIES OF CYPROHEPTADINE. Journal of Pharmacology and Experimental Therapeutics. 131(1). 73–84. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl T. Ludden Breakdown of academic impact, for papers by R Hahn Breakdown of academic impact, for papers by John M. Stavorski Breakdown of academic impact, for papers by Walter Osswald Breakdown of academic impact, for papers by Ho Sam Ahn Breakdown of academic impact, for papers by F Lefèvre-Borg Breakdown of academic impact, for papers by Irwin H. Slater Breakdown of academic impact, for papers by Jai D. Kohli Breakdown of academic impact, for papers by T. L. B. Spriggs Breakdown of academic impact, for papers by T J Verbeuren
Rankless by CCL
2026